Wellington Management Group LLP Sells 115,083 Shares of Option Care Health, Inc. $OPCH

Wellington Management Group LLP reduced its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 1.0% in the 2nd quarter, HoldingsChannel reports. The fund owned 11,782,384 shares of the company’s stock after selling 115,083 shares during the period. Wellington Management Group LLP owned about 0.08% of Option Care Health worth $247,077,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of OPCH. Advisory Services Network LLC bought a new stake in shares of Option Care Health in the third quarter worth $35,000. McIlrath & Eck LLC acquired a new stake in Option Care Health in the second quarter valued at $37,000. Caitong International Asset Management Co. Ltd bought a new position in Option Care Health during the 3rd quarter worth $38,000. Quarry LP raised its position in Option Care Health by 502.7% during the 3rd quarter. Quarry LP now owns 1,549 shares of the company’s stock worth $43,000 after purchasing an additional 1,292 shares during the last quarter. Finally, Employees Retirement System of Texas acquired a new position in Option Care Health during the 4th quarter worth about $45,000. Institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $23.90 on Monday. The company has a quick ratio of 0.98, a current ratio of 1.47 and a debt-to-equity ratio of 0.91. Option Care Health, Inc. has a twelve month low of $18.01 and a twelve month high of $36.80. The company has a fifty day moving average of $22.58 and a 200-day moving average of $25.17. The firm has a market capitalization of $3.58 billion, a P/E ratio of 17.97, a P/E/G ratio of 1.38 and a beta of 0.65.

Option Care Health (NASDAQ:OPCH) last issued its earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.02. The business had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.42 billion. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. Option Care Health’s revenue was up 1.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.41 earnings per share. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. As a group, sell-side analysts anticipate that Option Care Health, Inc. will post 1.69 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. Wall Street Zen upgraded Option Care Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 1st. The Goldman Sachs Group started coverage on Option Care Health in a research report on Monday, June 8th. They set a “neutral” rating and a $22.00 price objective for the company. JPMorgan Chase & Co. cut their price objective on Option Care Health from $40.00 to $33.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. Zacks Research upgraded Option Care Health from a “strong sell” rating to a “hold” rating in a report on Monday, July 6th. Finally, UBS Group restated a “buy” rating on shares of Option Care Health in a report on Tuesday, June 16th. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $29.92.

Option Care Health Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.